找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Erythropoietin; Wolfgang Jelkmann,Andreas J. Gross Conference proceedings 1989 Springer-Verlag Berlin Heidelberg 1989 anemia.blood.cells.c

[復(fù)制鏈接]
樓主: 調(diào)停
41#
發(fā)表于 2025-3-28 14:41:37 | 只看該作者
terleukin-3 (IL-3), the colony-stimulating factors (CSF) and erythropoietin (Epo) [8, 13, 62]. While the CSF induce the proliferation and differentiation of the pluripotent and committed progenitor cells [8], maturation of the late erythroid progenitors and erythroid precursors is mainly controlled by Epo [25].
42#
發(fā)表于 2025-3-28 21:48:36 | 只看該作者
Chemistry and Assays of Erythropoietin. Epo is the principal regulatory hormone of the circulating red cell mass [1,2] and is normally present in minute concentrations in serum at 15–30 milliunits/ml, or approximately 10. . [3–5]. The study of Epo has been hampered for many years by its extreme scarcity and the lack of a convenient assay.
43#
發(fā)表于 2025-3-28 23:15:16 | 只看該作者
44#
發(fā)表于 2025-3-29 06:10:51 | 只看該作者
45#
發(fā)表于 2025-3-29 07:17:57 | 只看該作者
46#
發(fā)表于 2025-3-29 14:54:15 | 只看該作者
Recombinant Human Erythropoietinttention must be paid to its quality in the sense of a functional replacement of the natural hormone. Accordingly, a detailed comparison of the human urinary extracted form with the recombinant product is given. For better understanding, the efforts at cloning and expression of the hormone in various cellular systems are discussed.
47#
發(fā)表于 2025-3-29 17:50:07 | 只看該作者
Recombinant Human Erythropoietin and ,-Retinoic Acid Therapy of Anemia in Hemodialysis and Peritonea the deficient production of erythropoietin (EPO) by the kidney [1–3]. This is confirmed by the very recent results concerning recombinant human erythropoietin (rHuEPO) use in uremic dialysis patients, which showed that intravenous administration of this hormone leads to a significant improvement in erythropoiesis [4–6].
48#
發(fā)表于 2025-3-29 20:51:12 | 只看該作者
49#
發(fā)表于 2025-3-30 02:50:41 | 只看該作者
50#
發(fā)表于 2025-3-30 07:07:47 | 只看該作者
Overview: 978-3-642-83747-0978-3-642-83745-6
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-22 07:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
灌南县| 苍溪县| 宁武县| 莱芜市| 永州市| 娄底市| 乡城县| 山西省| 栖霞市| 邹平县| 本溪市| 离岛区| 桃园县| 南华县| 沂水县| 巴东县| 桂平市| 宣武区| 平塘县| 延寿县| 礼泉县| 兰坪| 兴山县| 桓仁| 井冈山市| 大安市| 南溪县| 筠连县| 仙居县| 平邑县| 白山市| 都昌县| 陆河县| 措美县| 泾川县| 尖扎县| 海兴县| 太仆寺旗| 安溪县| 安义县| 三明市|